← Leaderboards
Ngan F. Huang
Veterans Admin Palo Alto Health Care Sys
$5,773,333
Attributed
$8,020,882
Total exposure
18
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,020,882 · 11
VA$0 · 7
By mechanism
R01$5,124,374 · 3
R21$1,486,250 · 3
R00$742,020 · 1
R41$340,956 · 1
K99$265,572 · 1
F32$51,710 · 1
Top collaborators
- Sarah C Heilshorn6 shared
- Kara E Mccloskey4 shared
- Michael Vitoldovich Paukshto2 shared
- Jessica Yelena Breland1 shared
- Xiaojing J Gao1 shared
- Odette A Harris1 shared
- Ji Eun Lee1 shared
Others in their field
Top investigators on “Endothelial Cells”
- Keri Hammel · The Emmes Company, Llc$41,089,609
- Martin Friedlander · Scripps Research Institute$38,298,285
- Michael Simons · Yale University$37,176,481
- Ajit P Varki · University Of California San Diego$34,208,221
- Joseph C Wu · Stanford University$33,648,524
- Jan E Schnitzer · Sidney Kimmel Cancer Center$31,414,677
Research focus
Endothelial CellsCellsCell SurvivalTissuesIn VitroBlood VesselsMouse ModelCuesBiocompatible MaterialsIn VivoInduced Pluripotent Stem CellHistologicIschemiaNatural RegenerationPeripheral Arterial DiseaseAnimal ModelLasersSpectrum AnalysisScaffoldEndotheliumHindlimbTransplantationStem CellsMediating
Grant awards (47)
Development of a Bioengineered Therapeutic Device for the Prevention of Lymphedema$540,476
R01 · FY2025 · CA · contact PI
Enhance Cell Therapies for Peripheral Arterial Disease Using Human-Compatible Protease-Based Controls$410,449
R21 · FY2025 · HL
Biomaterials for delivery and maintenance of tip endothelial cells$181,976
R21 · FY2025 · HL
Biomaterials for delivery and maintenance of tip endothelial cells$145,760
R21 · FY2025 · HL
2024-2026 Biomedical Engineering Society (BMES) Cellular and Molecular Bioengineering (CMBE) Conference$10,000
R13 · FY2025 · EB · contact PI
Engineering Vascularized Skeletal Muscle for Treatment of Volumetric Muscle Loss$0
I01 · FY2025 · VA · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2025 · VA · contact PI
Combining Prostaglandin E2 Modulation and Rehabilitation for Treatment of Volumetric Muscle Loss$0
I21 · FY2025 · VA · contact PI
VA Palo Alto Health Services & Life Sciences Summer Research Program: Enhancing the VA Research Pipeline$0
I01 · FY2025 · VA
BCCMA: Vascular Regeneration for PAD: Therapeutic Delivery of Angiogenic Stem Cells and mRNA-Based Gene Therapy$0
I01 · FY2025 · VA · contact PI
Development of a Bioengineered Therapeutic Device for the Prevention of Lymphedema$556,684
R01 · FY2024 · CA · contact PI
Biomaterials for delivery and maintenance of tip endothelial cells$237,505
R21 · FY2024 · HL
Biomaterials for delivery and maintenance of tip endothelial cells$77,635
R21 · FY2024 · HL
Combining Prostaglandin E2 Modulation and Rehabilitation for Treatment of Volumetric Muscle Loss$0
I21 · FY2024 · VA · contact PI
Engineering Vascularized Skeletal Muscle for Treatment of Volumetric Muscle Loss$0
I01 · FY2024 · VA · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2024 · VA · contact PI
Novel Highly Regenerative and Scalable Progenitor Cell Exosomes for Treating Peripheral Artery Disease$340,956
R41 · FY2023 · HL
Muscle stem cell therapy for volumetric muscle loss$0
I01 · FY2023 · VA · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2023 · VA · contact PI
Engineering Vascularized Skeletal Muscle for Treatment of Volumetric Muscle Loss$0
I01 · FY2023 · VA · contact PI
Engineered matrix microarrays to enhance the regenerative potential of iPSC-derived endothelial cells$392,872
R01 · FY2021 · HL · contact PI
Muscle stem cell therapy for volumetric muscle loss$0
I01 · FY2021 · VA · contact PI
Engineering Vascularized Skeletal Muscle for Treatment of Volumetric Muscle Loss$0
I01 · FY2021 · VA · contact PI
Aligned Nanofibrillar Scaffolds Enhance Angiogenesis and Viability in Ischemia$436,139
R01 · FY2020 · HL · contact PI
Engineered matrix microarrays to enhance the regenerative potential of iPSC-derived endothelial cells$392,861
R01 · FY2020 · HL · contact PI
Engineering Vascularized Skeletal Muscle for Treatment of Volumetric Muscle Loss$0
I01 · FY2020 · VA · contact PI
Aligned Nanofibrillar Scaffolds Enhance Angiogenesis and Viability in Ischemia$478,219
R01 · FY2019 · HL · contact PI
Engineered matrix microarrays to enhance the regenerative potential of iPSC-derived endothelial cells$392,500
R01 · FY2019 · HL · contact PI
Aligned Nanofibrillar Scaffolds Enhance Angiogenesis and Viability in Ischemia: Sex Differences Administrative Supplement$156,992
R01 · FY2019 · HL · contact PI
Engineering Vascularized Skeletal Muscle for Treatment of Volumetric Muscle Loss$0
I01 · FY2019 · VA · contact PI
Aligned Nanofibrillar Scaffolds Enhance Angiogenesis and Viability in Ischemia$471,543
R01 · FY2018 · HL · contact PI
Engineered matrix microarrays to enhance the regenerative potential of iPSC-derived endothelial cells$392,500
R01 · FY2018 · HL · contact PI
Vascularized Cardiac Patch with Physiological Orientation for Myocardial Repair$0
I01 · FY2018 · VA · contact PI
Aligned Nanofibrillar Scaffolds Enhance Angiogenesis and Viability in Ischemia$471,846
R01 · FY2017 · HL · contact PI
Vascularized Cardiac Patch with Physiological Orientation for Myocardial Repair$0
I01 · FY2017 · VA · contact PI
Aligned Nanofibrillar Scaffolds Enhance Angiogenesis and Viability in Ischemia$399,346
R01 · FY2016 · HL · contact PI
Matrix-mediated endothelial differentiation of induced pluripotent stem cells$249,000
R00 · FY2016 · HL · contact PI
Injectable Hydrogels to Improve the Efficacy of iPSC-derived Therapies$189,350
R21 · FY2016 · EB
Aligned Nanofibrillar Scaffolds Enhance Angiogenesis and Viability in Ischemia$42,396
R01 · FY2016 · HL · contact PI
Vascularized Cardiac Patch with Physiological Orientation for Myocardial Repair$0
I01 · FY2016 · VA · contact PI
Injectable Hydrogels to Improve the Efficacy of iPSC-derived Therapies$243,575
R21 · FY2015 · EB
Vascularized Cardiac Patch with Physiological Orientation for Myocardial Repair$0
I01 · FY2015 · VA · contact PI
Matrix-mediated endothelial differentiation of induced pluripotent stem cells$244,020
R00 · FY2014 · HL · contact PI
Matrix-mediated endothelial differentiation of induced pluripotent stem cells$249,000
R00 · FY2013 · HL · contact PI
Matrix-mediated endothelial differentiation of induced pluripotent stem cells$132,786
K99 · FY2011 · HL · contact PI
Matrix-mediated endothelial differentiation of induced pluripotent stem cells$132,786
K99 · FY2010 · HL · contact PI
High throughput screening of embryonic stem cell differentiation$51,710
F32 · FY2009 · HL · contact PI